Oct 8, 2026
Steve Beard, CEO of Covista, is addressing the growing healthcare workforce shortage through centers of learning that serve working adults, veterans, career changers, and internationally trained clinicians seeking domestic certification. Steve challenges the assumption that scale and quality are mutually exclusive and...
Oct 8, 2026
Steve Beard, CEO of Covista, is addressing the growing healthcare workforce shortage through centers of learning that serve working adults, veterans, career changers, and internationally trained clinicians seeking domestic certification. Steve challenges the assumption that scale and quality are mutually exclusive and...
Oct 7, 2026
Dr. John Friend, CEO of Kazia Therapeutics, is investigating how to change the underlying biology that lets cancers resist treatment and evade the immune system. A central challenge in oncology is that cancer cells adapt and suppress immune recognition. Reprogramming the biology includes altering immune evasion...
Oct 7, 2026
Dr. John Friend, CEO of Kazia Therapeutics, is investigating how to change the underlying biology that lets cancers resist treatment and evade the immune system. A central challenge in oncology is that cancer cells adapt and suppress immune recognition. Reprogramming the biology includes altering immune evasion...
Oct 6, 2026
Leo Petrossian, CEO of Kandu, discusses a groundbreaking approach to stroke recovery that uses an FDA-cleared, non-invasive EEG headset combined with a robotic glove that detects when a patient visualizes moving their impaired arm and simultaneously moves the arm mechanically. Traditional rehabilitation has treated the...